| ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) (NCT07741461) | Xiamen Amoytop Biotech Co., Ltd. | 2026-08-06 |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature (NCT07614152) | Xiamen Amoytop Biotech Co., Ltd. | 2026-07-05 |
| Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency (NCT07551804) | Xiamen Amoytop Biotech Co., Ltd. | 2026-06-10 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B (NCT07589400) | Xiamen Amoytop Biotech Co., Ltd. | 2026-05-30 |
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) (NCT07462455) | Xiamen Amoytop Biotech Co., Ltd. | 2026-03-31 |
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. (NCT07408908) | Xiamen Amoytop Biotech Co., Ltd. | 2026-03-06 |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age (NCT07309562) | Xiamen Amoytop Biotech Co., Ltd. | 2026-01-20 |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature (NCT06927310) | Xiamen Amoytop Biotech Co., Ltd. | 2025-04-28 |
| Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants (NCT06716905) | Xiamen Amoytop Biotech Co., Ltd. | 2025-03-06 |
| Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET (NCT06552429) | Xiamen Amoytop Biotech Co., Ltd. | 2024-08-29 |
| A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B (NCT06707922) | Xiamen Amoytop Biotech Co., Ltd. | 2022-03-18 |
| A Trial of YPEG-rhGH in Children With Short Stature (NCT05838885) | Xiamen Amoytop Biotech Co., Ltd. | 2022-02-15 |
| A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease (NCT04885647) | Xiamen Amoytop Biotech Co., Ltd. | 2021-03-12 |
| Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy (NCT04466137) | Xiamen Amoytop Biotech Co., Ltd. | 2020-10-16 |
| A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B (NCT04846491) | Xiamen Amoytop Biotech Co., Ltd. | 2019-12-04 |
| Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children (NCT04513171) | Xiamen Amoytop Biotech Co., Ltd. | 2018-12-26 |